中文介绍:
Azido-PEG4-NHS ester是一种非常受欢迎的PEG试剂,它含有叠氮基团和NHS酯。亲水性PEG间隔物增加了在水性介质中的溶解度。叠氮基团可以通过点击化学与炔、BCN、DBCO反应,产生稳定的三唑键。NHS酯可用于标记蛋白质的伯胺(-NH2)、胺修饰的寡核苷酸和其他含胺分子。
英文介绍:
Azido-PEG4-NHS ester is a very popular PEG reagent which containan azide group and an NHS ester. The hydrophilic PEG spacer increases solubility in aqueous media. The azide group can react with alkyne, BCN, DBCO via Click Chemistry to yield a stable triazole linkage. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.
产品详情:
Azido-PEG4-NHS Ester 叠氮-四聚乙二醇-NHS脂 CAS944251-24-5
产品英文名称:Azido-PEG4-NHS Ester
产品中文名称:叠氮-四聚乙二醇-乙烯酸琥珀酰亚胺
分子量:388.37
分子式:C15H24N4O8
CAS:944251-24-5
溶解度:DMSO、DMF、DCM、THF、氯仿
纯度>95%(液相色谱法)
外观:无色至微黄色油
储存条件:-20°C.干燥剂
装运条件环境温度
描述:Azido-PEG4-NHS酯是一种标记试剂,可用于通过稳定的酰胺键修饰带有Azido基的伯胺基(例如,赖氨酸残基的侧链或氨基硅烷涂层表面)。叠氮化物(N3)基团通过CuAAC与末端炔烃反应,通过无铜点击反应与应变环辛基(例如DBCO或BCN化合物)反应,或通过一种称为Staudinger化学的机制与膦标记分子反应,从而实现生物样品中衍生分子的和特异的共轭。
产品被引文献:
1.Brunel, L. G., Cai, B., Hull, S. M., Han, U., Wungcharoen, T., Fernandes-Cunha, G. M., ... & Myung, D. (2024). In Situ UNIversal Orthogonal Network (UNION) Bioink Deposition for Direct Delivery of Corneal Stromal Stem Cells to Corneal Wounds. bioRxiv, 2024-09.
doi.org/10.1101/2024.09.19.613997
2.Brunel, L. G., Long, C. M., Christakopoulos, F., Cai, B., Johansson, P. K., Singhal, D., ... & Heilshorn, S. C. (2024). Interpenetrating networks of fibrillar and amorphous collagen promote cell spreading and hydrogel stability. bioRxiv, 2024-09.
doi.org/10.1101/2024.09.11.612534
3.Hull SM, Lindsay CD, et al 3D Bioprinting using UNIversal Orthogonal Network (UNION) Bioinks. Advanced Functional Materials. 2021. 31(7). 2007983
doi/am-pdf/10.1002/adfm.202007983
4.Mapes, J. H., Stover, J., Stout, H. D., Folsom, T. M., Babcock, E., Loudwig, S., ... & Swaminathan, J. (2023). Robust and scalable single-molecule protein sequencing with fluorosequencing. bioRxiv, 2023-09.
biorxiv.org/content/10.1101/2023.09.15.558007v1.full.pdf